A Post-marketing surveillance study for tofacitinib in patients with ulcerative colitis
Latest Information Update: 08 Dec 2021
At a glance
- Drugs Tofacitinib (Primary)
- Indications Ulcerative colitis
- Focus Adverse reactions
- 09 Oct 2021 Results assessing post-marketing surveillance case safety reports for tofacitinib in patients with ulcerative colitis, published in the Alimentary Pharmacology and Therapeutics..
- 05 Jul 2021 New trial record
- 23 May 2021 Results presented at the Digestive Disease Week 2021.